COMMUNIQUÉS West-GlobeNewswire
-
Medicana Health Group Conducts Pre-World Cup Health Checks for the Türkiye National Football Team
18/06/2026 -
NMDP Teams Up with Boozer Brothers to Help More Patients Access Blood Stem Cell Transplants
18/06/2026 -
FamilyWell Health Launches Menopause Hub, Setting the Standard for Behavioral Health in Midlife Care
18/06/2026 -
Chiesi Global Rare Diseases Highlights Advancements in Lipodystrophy Research at ENDO 2026
18/06/2026 -
New Phase 2a Clinical Data Analysis of Stem Cell Therapy Laromestrocel in Mild Alzheimer’s Disease Accepted for Poster Presentation at the 2026 Alzheimer’s Association International Conference (AAIC)
18/06/2026 -
AIM ImmunoTech Achieves Clinical Milestone as Final Subject Receives First Dose in Phase 2 DURIPANC Study in Metastatic Pancreatic Cancer
18/06/2026 -
Daré Bioscience to Showcase Leadership in Women's Health Innovation at BIO International Convention 2026
18/06/2026 -
PracticeLink Announces Spring 2026 First Practice Fund Scholarship Recipients
18/06/2026 -
SK pharmteco annonce une collaboration stratégique avec Orphan Therapeutics Accelerator pour le développement et la fabrication de produits thérapeutiques visant les maladies rares
18/06/2026 -
Court victory paves the way for Curium’s plans to provide targeted radioligand therapy to U.S. patients with GEP-NETs
18/06/2026 -
VERAXA Biotech Establishes in vitro Proof-of-Concept for Novel BiTAC-ADC Technology Platform and Launches Partnering Discussions at BIO International Convention 2026
18/06/2026 -
23andMe Research Institute Appoints Hillary Aiken as Head of Philanthropy & Development
18/06/2026 -
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
18/06/2026 -
R1 Accelerates Real-Time Adjudication with New Phare OS Intelligence Engine
18/06/2026 -
Hi*Ball Energy Arrives in the UK, Leading a New Wave of Clean Energy
18/06/2026 -
Oncotelic Launches AI-Powered GMP Manufacturing Services Platform at BIO International Convention 2026
18/06/2026 -
Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million
18/06/2026 -
Grace Therapeutics Announces 2026 Fiscal Year-End Financial Results, Provides Business Update
18/06/2026 -
Clearmind Medicine Granted U.S. Patent for Binge Behavior Regulators
18/06/2026
Pages